Tuesday, January 14th, 2025
Log in
Search
Subscribe to Digest
Donate
Remove Ads

Suchitra Pandey

Research
People who have recovered from COVID-19 have antibodies in their blood’s plasma that may help fight the virus. The new treatment, which has been approved as an investigational product by the U.S. Food and Drug Administration, aims to utilize these antibodies by transferring them to patients who are currently battling the virus. (Photo courtesy of Stanford Blood Center)

Stanford Blood Center organizes plasma donation drive for potential COVID-19 treatment

Meghan Sullivan
  •  
April 26, 2020
Health
Because of the Santa Clara County “shelter in place” order, Stanford Blood Center has been seeing a lack of donors and is projected to lose over 700 blood products within the next 30 days. (Photo courtesy of Stanford Blood Center)

Stanford Blood Center faces shortages in light of COVID-19

Camryn Pak
  •  
March 19, 2020
The Stanford Daily

Login or create an account